Hikari Tsushin, Inc., together with its subsidiaries, engages in the provision and sale of gas and electricity. It operates through Electricity and Gas, Communication, Beverage, Insurance, Finance, Solution, and Sales Agency segments. The company also offers communication line and ancillary services; life and non-life insurance products, and guarantee services; and microfinance. In addition, it manufactures, sells, and delivers natural mineral water; provides industry-specific solutions, such as customer and payment management systems; and operates as a sales agency for various telecommunication products. The company serves individuals, and small and medium-sized enterprises. Hikari Tsushin, Inc. was incorporated in 1952 and is headquartered in Toshima, Japan.
Frequently asked questions
What sector does Hikma Pharmaceuticals PLC (HIK) operate in?
Hikma Pharmaceuticals PLC belongs to the Industrials sector and operates in the Conglomerates industry.
What is Hikma Pharmaceuticals PLC (HIK) current stock price?
As of the latest data, Hikma Pharmaceuticals PLC stock price is €214.00, with a previous close of €212.00. Hikma Pharmaceuticals PLC gained €2.00 in the last trading session, representing a 0.94% increase.
What is Hikma Pharmaceuticals PLC (HIK) current market capitalization?
Hikma Pharmaceuticals PLC market cap is approximately 9.40 billion.
What is Hikma Pharmaceuticals PLC (HIK) Earnings Per Share (EPS)?
The trailing EPS is €20.17.
What is Hikma Pharmaceuticals PLC (HIK) Price-to-Earnings (P/E) ratio?
Hikma Pharmaceuticals PLC current P/E ratio is 10.61.
Does Hikma Pharmaceuticals PLC (HIK) pay dividends?
Yes. Hikma Pharmaceuticals PLC pays quarterly dividends with an annualized yield of 0.01% and an estimated annual payout of €4.54 per share.
When is the next ex-dividend date for Hikma Pharmaceuticals PLC (HIK)?
The next ex-dividend date is scheduled for December 29, 2026.
When is Hikma Pharmaceuticals PLC (HIK) next earnings report?
Hikma Pharmaceuticals PLC is expected to release its next earnings report on September 30, 2026.
What is Hikma Pharmaceuticals PLC (HIK) beta (volatility) score?
Hikma Pharmaceuticals PLC has a beta of 0.289, indicating lower volatility than the overall market.
